BOZITINIB (PLB-1001)
|
|
|
- CAS号:
- 1440964-89-5
- 英文名:
- PLB-1001
- 英文别名:
- CBT-101;BOZITINIB;PLB-1001 ;Vebreltinib;BOZITINIB (PLB-1001);Bozitinib (Vebreltinib);CBT101,CBT 101,Vebreltinib,PLB 1001,PLB1001,inhibit,Bozitinib,c-Met/HGFR,Inhibitor;6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;6-(1-cyclopropyl-1H-pyrazolyl)-3- (difluoro(6-fluoro-2-rnelhyl-2H-indazol-5-yl) methy)-[1,2,4]triazolo[4,3-b] pyridazine;6-(1-cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl)-[1,2,4]triazolo[4,3-b]pyridazine
- 中文名:
- BOZITINIB (PLB-1001)
- 中文别名:
- APL-101;化合物BOZITINIB;伯瑞替尼(PLB-1001);PLB-1001; CBT-101; VEBRELTINIB;6-(1-CYCLOPROPYL-1H-PYRAZOL-4-YL)-3-(DIFLUORO(6-FLUORO-2-METHYL-2H-INDAZOL-5-YL)METHYL)-[1,2,4]TRIAZ
- CBNumber:
- CB44923804
- 分子式:
- C20H15F3N8
- 分子量:
- 424.38
- MOL File:
- 1440964-89-5.mol
|
|
|
BOZITINIB (PLB-1001)化学性质
-
密度:
-
1.68±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO: 50 mg/mL (117.82 mM)
-
|
-
酸度系数(pKa):
-
0.15±0.12(Predicted)
-
|
BOZITINIB (PLB-1001)性质、用途与生产工艺
Bozitinib (PLB-1001, CBT-101, APL-101, CBI-3103)是一种具有血脑屏障通透性的高选择性ATP竞争性 c-Met 抑制剂。Bozitinib (PLB-1001) 在临床前模型中可选择性地抑制MET改变的肿瘤细胞。
BOZITINIB (PLB-1001)
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-125017 | Bozitinib | | 1 mg | 1333元 |
| 2024/04/30 | S6762 | BOZITINIB (PLB-1001)
Bozitinib (PLB-1001) | 1440964-89-5 | 2mg | 1790.4元 |
BOZITINIB (PLB-1001)
生产厂家
1440964-89-5, BOZITINIB (PLB-1001) 相关搜索:
- 合成有机化合物配体
- 医药原料
- C20H15F3N8
- 伯瑞替尼(PLB-1001)
- PLB-1001; CBT-101; VEBRELTINIB
- 6-(1-CYCLOPROPYL-1H-PYRAZOL-4-YL)-3-(DIFLUORO(6-FLUORO-2-METHYL-2H-INDAZOL-5-YL)METHYL)-[1,2,4]TRIAZ
- APL-101
- 化合物BOZITINIB
- 1440964-89-5
- Bozitinib (Vebreltinib)
- 6-(1-cyclopropyl-1H-pyrazolyl)-3- (difluoro(6-fluoro-2-rnelhyl-2H-indazol-5-yl) methy)-[1,2,4]triazolo[4,3-b] pyridazine
- CBT101,CBT 101,Vebreltinib,PLB 1001,PLB1001,inhibit,Bozitinib,c-Met/HGFR,Inhibitor
- 6-(1-cyclopropyl-1H-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl)-[1,2,4]triazolo[4,3-b]pyridazine
- Vebreltinib
- 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
- 1,2,4-Triazolo[4,3-b]pyridazine, 6-(1-cyclopropyl-1H-pyrazol-4-yl)-3-[difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl]-
- CBT-101
- BOZITINIB (PLB-1001)
- BOZITINIB
- PLB-1001